Study | Sample size | Median Follow-up (months) | Outcome | Design | |
---|---|---|---|---|---|
Allo-SCT | Non-allo-SCT | ||||
Attal [9] | 41 | 64 | 30 | DFS | Randomized trial |
Bernasconi [10] | 11 | 29 | 48 | DFS | Clinical trial |
Cornelissen [11] | 96 | 161 | 65 | OS, DFS | Clinical trial |
De Witte [12] | 30 | 33 | 60 | OS, DFS | Clinical trial |
Fielding [13] | 81 | 77 | 98 | OS, DFS | Clinical trial |
Goldstone [14] | 443 | 588 | 59 | OS, DFS | Clinical trial |
Hunault [15] | 41 | 106 | 61 | OS, DFS | Randomized¶ trial |
Ifrah [16] | 18 | 32 | 60 | DFS | Clinical trial |
Labar [17] | 68 | 116 | 114 | OS, DFS | Clinical trial |
Ribera [18] | 84 | 98 | 70 | OS, DFS | Clinical trial |
Sebban [19] | 116 | 141 | 62 | OS, DFS | Clinical trial |
Thomas [21] | 100 | 159 | 62 | OS, DFS | Clinical trial |
Takeuchi [20] | 34 | 108 | 63 | OS, DFS | Clinical trial |
Ueda [22] | 17 | 40 | 62 | OS, DFS | Clinical trial |